BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 7689741)

  • 1. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 2. Retroperitoneal lymphadenectomy remains the treatment of choice in nonseminomatous germ cell tumors.
    Graham SD
    Semin Urol; 1993 May; 11(2):85-91. PubMed ID: 8395700
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal lymph node dissection in testicular cancer.
    Jacobsen NE; Foster RS; Donohue JP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
    Lieskovsky G; Weinberg AC; Skinner DG
    Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
    Powles T
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview: treatment of local regional disease.
    Donohue JP
    Prog Clin Biol Res; 1990; 350():283-93. PubMed ID: 2166958
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
    Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
    Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of postchemotherapy surgery in managing metastatic germ cell tumors.
    Beck SD
    Cancer; 2007 Dec; 110(12):2601-3, i. PubMed ID: 17948907
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum markers in germ cell neoplasms.
    Bartlett NL; Freiha FS; Torti FM
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy.
    Peckham MJ
    Prog Clin Biol Res; 1985; 203():523-38. PubMed ID: 2421341
    [No Abstract]   [Full Text] [Related]  

  • 18. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
    Scardino PT; Skinner DG
    Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.